BINV BioInvent International AB (publ)

0.2136USD2.170 SEK · STO-17.02%Mkt Cap: 14.06M USDP/E: —

BioInvent International AB (publ), a clinical-stage company, discovers and develops immuno-modulatory antibodies for cancer therapy in Sweden, Europe, the United States, and internationally. The company's drug candidates…

Institutional holders7 on file

Key Statistics

Company
Market Cap14.06M USD
Enterprise Value-6.15M USD
Revenue (TTM)3.94M USD
Gross Profit3.94M USD
Net Income (TTM)-32.76M USD
Revenue/Share0.06 USD
Last Price0.2136 USD
Fiscal Year EndDec 2025
MR QuarterSep 2026
Employees107
CountrySE
SectorHealthcare
IndustryBiotechnology
ISINSE0015244520
Valuation
P/E (Trailing)—
P/E (Forward)-0.55
PEG0.27
EV/EBITDA0.13
EV/Revenue-1.56
P/S3.57
P/B0.71
EPS (TTM)-0.73 USD
EPS (Forward)-0.39 USD
52W Range
0.18701% of range3.420
52W High3.420 USD
52W Low0.1870 USD
Profitability
Gross Margin100.00%
Oper. Margin-1241.16%
EBITDA Margin0.00%
Profit Margin-146.96%
ROE-59.69%
ROA-49.59%
ROIC—
ROCE-62.87%
Growth
Revenue Growth225.00%
Earnings Growth—
Cash Flow & Leverage
Operating CF-24.39M USD
CapEx (TTM)714.60K USD
FCF Margin-701.95%
FCF Yield-196.54%
Net Debt-20.20M USD
Net Debt/EBITDA0.42
Net Debt/FCF—
Balance Sheet
Debt/Equity0.02
Current Ratio2.80
Quick Ratio2.69
Book Value/Sh0.30 USD
Cash/Share0.34 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:25
Split DateDec 14, 2020
Analyst Consensus
Rating2.0 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)5.519 USD
Upside (mean)+2483.7%
Target Range0.4232 USD – 8.859 USD
0.4232+2483.7% to mean8.859
# Analysts3
Ownership
Shares Out.65.80M
Float31.44M
Insiders10.17%
Institutions57.68%
Technical
SMA 501.636 (-86.9%)
SMA 2002.176 (-90.2%)
Beta0.13
S&P 52W Chg12.00%
Avg Vol (30d)737.75K
Avg Vol (10d)816.30K
Technical Indicators
RSI (14)11.6
MACD-4.4513
MACD Signal-4.6578
MACD Hist.+0.2066
BB Upper2.070 USD
BB Middle0.6724 USD
BB Lower-0.7255 USD
BB Width415.81%
ATR (14)0.1055 USD
Vol Ratio (20d)0.57x

About BioInvent International (STO: BINV)

›

BioInvent International (STO: BINV) is listed on Nasdaq Stockholm, where its shares trade in SEK. It belongs to the Biotechnology industry, part of the Healthcare sector, and reports about 107 employees.

The shares were at 2.170 SEK on 19 November 2026, down 93.0% over 52 weeks. Its 52-week range is 1.900 SEK to 34.75 SEK: the price is 93.8% below the high and 14.2% above the low.

Its market capitalisation is 142.80M SEK.

BioInvent International reports return on equity of -59.7% and revenue up 225.0% year over year.

It holds more cash than debt, a net cash position of 205.24M SEK. Its Piotroski F-score is 4 out of 9, an average reading of its financial health. The next earnings report is expected on 4 March 2027.